Blastic Plasmacytoid Dendritic Cell Neoplasm A 10-year Bibliometric Study

• Published in: Journal of Applied Hematology Vol. 14; no. 1; pp. 12 - 16
• Main Authors: Quispe-Vicuna, Carlos, Cabanillas-Lazo, Miguel, Barja-Ore, John, Mauricio-Vilchez, Cesar, Guerrero, Maria Eugenia, Munive-Degregori, Arnaldo, Mayta-Tovalino, Frank
• Format: Journal Article
• Language: English
• Published: 01.01.2023
• ISSN: 1658-5127
• DOI: 10.4103/joah.joah_81_22

INTRODUCTION: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological disease. There is an incidence. We aimed to evaluate the scientometrics characteristics of the scientific production on BPDCN between 2011 and 2020. METHODOLOGY: A cross-sectional and retrospective bibliometric study was performed. The search was executed in the Scopus database. Data were extracted based on a formula developed using thesaurus MeSH (Medline) and Emtree (Embase) terms. The retrieved papers received 11.2 citations per paper. Four of the ten most productive authors were from the United States. The institution with the highest impact (1064 citations) and the highest scientific output (46 papers) was the University of Texas MD Anderson Cancer Center (United States). RESULTS: The journal “Movement Disorders” rated first with 18 articles and 643 citations in terms of productivity and impact, and articles published in Q1 journals surpassed the remaining quartiles. The most cited articles had national collaboration. Conclusion the number of papers on BPDCN has been rising, yet journals with a higher quality tend to keep the similar publication rates, although they have shown a slight increase in the recent years. CONCLUSIONS: High-income countries' international collaboration is crucial for increasing publications impact; hence, greater collaborations between researchers and institutions from countries around the world are needed to expand knowledge on this subject.